Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Bupivacaine Hydrochloride for Superior Trunk Block in Shoulder Surgery
NCT07587203Enrolling by invitation
- Sponsor
- Nanjing First Hospital
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Incidence of hemi-diaphragmatic paralysis. Started Jun 2026; status: enrolling by invitation.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07587203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587203.